{
    "clinical_study": {
        "@rank": "45070", 
        "arm_group": [
            {
                "arm_group_label": "6 months to < 36 months of age group", 
                "arm_group_type": "Experimental", 
                "description": "Participants at 6 months to < 36 months of age at the time of enrollment will receive Influenza Virus Vaccine, No Preservative; Fluzone\u00ae (Pediatric Dose)."
            }, 
            {
                "arm_group_label": "3 years to < 9 years of age group", 
                "arm_group_type": "Experimental", 
                "description": "Participants at 3 years to < 9 years of age at the time of enrollment will receive Influenza Virus Vaccine, No Preservative; Fluzone\u00ae."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this clinical study is to demonstrate safety and immunogenicity of Fluzone\n      vaccine.\n\n      Objective:\n\n        -  To describe the safety of the 2012-2013 formulation of Fluzone vaccine, administered in\n           a 1- or 2-dose schedule, in accordance with Advisory Committee on Immunization\n           Practices (ACIP) recommendations, in children 6 months to < 9 years of age.\n\n      Observational Objectives:\n\n        -  To describe the immunogenicity of the 2012-2013 formulation of Fluzone vaccine,\n           administered in a 1- or 2-dose schedule in accordance with ACIP recommendations, in\n           children 6 months to < 9 years of age.\n\n        -  To submit remaining available sera from subjects to the Center for Biologics Evaluation\n           and Research (CBER) for further analysis by the World Health Organization (WHO), the\n           Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration\n           (FDA) to support selection and recommendation of strains for subsequent years'\n           influenza vaccines."
        }, 
        "brief_title": "Safety and Immunogenicity Among Healthy Children Receiving Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Participants 6 months to < 36 months of age that received one or two doses of 0.25 mL of Fluzone vaccine", 
                            "title": "Age 6 to < 36 Months Group"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Participants 3 years to < 9 years of age that received one or two doses of 0.5 mL of Fluzone vaccine", 
                            "title": "Age 3 to < 9 Years Group"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "30"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "30"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "60"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "30"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "30"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "60"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "0.6", 
                                                "@value": "1.8"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "1.6", 
                                                "@value": "5.2"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "1.2", 
                                                "@value": "3.5"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "Years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "14"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "13"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "27"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "16"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "17"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "33"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "30"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "30"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "60"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "Participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications"
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Solicited injection site reactions (Age 6 to < 24 Months): Tenderness, Erythema and Swelling. Solicited systemic reactions: Fever (Temperature), Vomiting, Abnormal crying, Drowsiness, Loss of appetite, and Irritability.\nGrade 3: Tenderness, Cries when injected limb is moved; Erythema and Swelling, \u2265 50 mm; Fever, >103.1\u00b0F; Vomiting, \u22656 episodes/24 hours; Abnormal crying, >3 hours; Drowsiness, Sleeping most of the time; Loss of appetite, Refuses \u22653 feeds/meals or most feeds/meals; Irritability, Inconsolable.\nSolicited injection site reactions (Age 24 Months to < 9 Years): Pain, Erythema, and Swelling. Systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nGrade 3: Pain, Incapacitating, unable to perform usual activities; Redness and Swelling, \u2265 50 mm; Fever: \u2265102.1\u00b0F; Headache, Malaise, and Myalgia, Significant, prevents daily activity.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants 6 months to < 36 months of age that received one or two doses of 0.25 mL of Fluzone vaccine", 
                                    "title": "Age 6 to < 36 Months Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants 3 years to < 9 years of age that received one or two doses of 0.5 mL of Fluzone vaccine", 
                                    "title": "Age 3 to < 9 Years Group"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "30"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "#text": "Injection site Tenderness was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Injection site Tenderness (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "#text": "Injection site Tenderness was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Tenderness (N =15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "13"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Injection site Pain (N =15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Pain (N = 15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "8"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "9"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Injection site Erythema (N = 30, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Erythema (N = 30, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Injection site Swelling (N = 30, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Injection site Swelling (N = 30, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Fever (N = 30, 28)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Fever (N = 30, 28)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "5"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Headache (N = 15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Headache (N = 15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "4"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Malaise (N = 15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Malaise (N = 15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Myalgia (N = 15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "0"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Myalgia (N = 15, 30)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "#text": "Vomiting was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Vomiting (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "#text": "Vomiting was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Vomiting (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "6"
                                                        }, 
                                                        {
                                                            "#text": "Abnormal crying was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Abnormal crying (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "#text": "Abnormal crying was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Abnormal crying (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "5"
                                                        }, 
                                                        {
                                                            "#text": "Drowsiness was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Drowsiness (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "#text": "Drowsiness was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Drowsiness (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "4"
                                                        }, 
                                                        {
                                                            "#text": "Loss of Appetite  was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Loss of Appetite (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "0"
                                                        }, 
                                                        {
                                                            "#text": "Loss of Appetite was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Loss of Appetite (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "9"
                                                        }, 
                                                        {
                                                            "#text": "Irritability was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Irritability (N = 15, 0)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "#text": "Irritability was not solicited in this group", 
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "NA"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "Grade 3 Irritability (N = 15, 0)"
                                            }
                                        ]
                                    }, 
                                    "description": "Solicited injection site reactions (Age 6 to < 24 Months): Tenderness, Erythema and Swelling. Solicited systemic reactions: Fever (Temperature), Vomiting, Abnormal crying, Drowsiness, Loss of appetite, and Irritability.\nGrade 3: Tenderness, Cries when injected limb is moved; Erythema and Swelling, \u2265 50 mm; Fever, >103.1\u00b0F; Vomiting, \u22656 episodes/24 hours; Abnormal crying, >3 hours; Drowsiness, Sleeping most of the time; Loss of appetite, Refuses \u22653 feeds/meals or most feeds/meals; Irritability, Inconsolable.\nSolicited injection site reactions (Age 24 Months to < 9 Years): Pain, Erythema, and Swelling. Systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nGrade 3: Pain, Incapacitating, unable to perform usual activities; Redness and Swelling, \u2265 50 mm; Fever: \u2265102.1\u00b0F; Headache, Malaise, and Myalgia, Significant, prevents daily activity.", 
                                    "param": "Number", 
                                    "title": "Number of Participants Reporting Solicited Injection Site or Systemic Reactions Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Solicited injection site reactions and systemic reactions were assessed using the Safety Analysis Set, which includes all persons who received at least one dose of study vaccine.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 0 up to Day 7 post-vaccination", 
                        "title": "Number of Participants Reporting Solicited Injection Site or Systemic Reactions Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "The influenza virus antibodies were measured using a hemagglutination inhibition (HAI) assay.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants 6 months to < 36 months of age that received one or two doses of 0.25 mL of Fluzone vaccine", 
                                    "title": "6 to < 36 Months Age Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants 3 years to < 9 years of age that received one or two doses of 0.5 mL of Fluzone vaccine", 
                                    "title": "3 to < 9 Years Age Group"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "25"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "9.93", 
                                                            "@upper_limit": "42.6", 
                                                            "@value": "20.6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "30.5", 
                                                            "@upper_limit": "155", 
                                                            "@value": "68.8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H1N1 (pre-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "189", 
                                                            "@upper_limit": "589", 
                                                            "@value": "334"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "559", 
                                                            "@upper_limit": "1337", 
                                                            "@value": "864"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H1N1 (post-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "11.4", 
                                                            "@upper_limit": "47.5", 
                                                            "@value": "23.3"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "49.5", 
                                                            "@upper_limit": "145", 
                                                            "@value": "84.8"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H3N2 (pre-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "296", 
                                                            "@upper_limit": "865", 
                                                            "@value": "506"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "585", 
                                                            "@upper_limit": "1369", 
                                                            "@value": "895"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H3N2 (post-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "4.76", 
                                                            "@upper_limit": "7.13", 
                                                            "@value": "5.82"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "7.42", 
                                                            "@upper_limit": "12.6", 
                                                            "@value": "9.66"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "B (pre-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "11.2", 
                                                            "@upper_limit": "24.8", 
                                                            "@value": "16.7"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "46.4", 
                                                            "@upper_limit": "105", 
                                                            "@value": "69.6"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "B (post-vaccination)"
                                            }
                                        ]
                                    }, 
                                    "description": "The influenza virus antibodies were measured using a hemagglutination inhibition (HAI) assay.", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Geometric Mean Titers of Antibodies to Influenza Antigens Before and Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation).", 
                                    "units": "Titers"
                                }
                            ]
                        }, 
                        "population": "Geometric mean titers of antibodies against the influenza virus antigens were assessed in the Per-protocol Analysis Set.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 0 (pre-vaccination) and Day 28 after final vaccination", 
                        "title": "Geometric Mean Titers of Antibodies to Influenza Antigens Before and Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation).", 
                        "type": "Other Pre-specified"
                    }, 
                    {
                        "description": "Influenza virus antibodies were measured using a HAI assay. Seroprotection was defined as a titer \u226540 (1/dilution).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants 6 months to < 36 months of age that received one or two doses of 0.25 mL of Fluzone vaccine", 
                                    "title": "Age 6 to < 36 Months Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants 3 years to < 9 years of age that received one or two doses of 0.5 mL of Fluzone vaccine", 
                                    "title": "Age 3 to < 9 Years Group"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "25"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "10"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "18"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H1N1 (pre-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "24"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H1N1 (post-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "11"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "20"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H3N2 (pre-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "25"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "30"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H3N2 (post-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "1"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "2"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "B (pre-vaccination)"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "21"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "B (post-vaccination)"
                                            }
                                        ]
                                    }, 
                                    "description": "Influenza virus antibodies were measured using a HAI assay. Seroprotection was defined as a titer \u226540 (1/dilution).", 
                                    "param": "Number", 
                                    "title": "Number of Participants With Seroprotection Before and Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Seroprotection against the influenza virus antigens were assessed in the Per-protocol Analysis Set.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 0 (pre-vaccination) and Day 28 after final vaccination", 
                        "title": "Number of Participants With Seroprotection Before and Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                        "type": "Other Pre-specified"
                    }, 
                    {
                        "description": "Influenza virus antibodies were measured using a HAI assay. Seroconversion was defined as a pre-vaccination titer <10 (1/dilution) and a post-vaccination titer \u226540 (1/dilution), or a pre-vaccination titer \u226510 (1/dilution) and \u22654-fold increase in titer 28 days after final vaccination.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants 6 months to < 36 months of age that received one or two doses of 0.25 mL of Fluzone vaccine", 
                                    "title": "Age 6 to < 36 Months Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants 3 years to < 9 years of age that received one or two doses of 0.5 mL of Fluzone vaccine", 
                                    "title": "Age 3 to < 9 Years Group"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "25"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "22"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "22"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H1N1"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "23"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "25"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H3N2"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@value": "5"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "0", 
                                                            "@upper_limit": "0", 
                                                            "@value": "20"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "B"
                                            }
                                        ]
                                    }, 
                                    "description": "Influenza virus antibodies were measured using a HAI assay. Seroconversion was defined as a pre-vaccination titer <10 (1/dilution) and a post-vaccination titer \u226540 (1/dilution), or a pre-vaccination titer \u226510 (1/dilution) and \u22654-fold increase in titer 28 days after final vaccination.", 
                                    "param": "Number", 
                                    "title": "Number of Participants With Seroconversion Against Influenza Virus Antigens Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                                    "units": "Participants"
                                }
                            ]
                        }, 
                        "population": "Seroconversion against the influenza virus antigens were assessed in the Per-protocol Analysis Set.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 28 after final vaccination", 
                        "title": "Number of Participants With Seroconversion Against Influenza Virus Antigens Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                        "type": "Other Pre-specified"
                    }, 
                    {
                        "description": "Influenza virus antibodies were measured using a HAI assay. Geometric mean titer ratio is the geometric mean of the individual post-vaccination / pre-vaccination titer of antibodies to the influenza virus antigens", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Participants 6 months to < 36 months of age that received one or two doses of 0.25 mL of Fluzone vaccine", 
                                    "title": "Age 6 to < 36 Months Group"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Participants 3 years to < 9 years of age that received one or two doses of 0.5 mL of Fluzone vaccine", 
                                    "title": "Age 3 to < 9 Years Group"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "25"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "30"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": [
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "7.24", 
                                                            "@upper_limit": "18.7", 
                                                            "@value": "11.6"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "5.56", 
                                                            "@upper_limit": "20.5", 
                                                            "@value": "10.7"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H1N1"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "9.45", 
                                                            "@upper_limit": "27.9", 
                                                            "@value": "16.2"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "5.88", 
                                                            "@upper_limit": "18.1", 
                                                            "@value": "10.3"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "A/H3N2"
                                            }, 
                                            {
                                                "measurement_list": {
                                                    "measurement": [
                                                        {
                                                            "@group_id": "O1", 
                                                            "@lower_limit": "1.29", 
                                                            "@upper_limit": "2.55", 
                                                            "@value": "1.82"
                                                        }, 
                                                        {
                                                            "@group_id": "O2", 
                                                            "@lower_limit": "3.75", 
                                                            "@upper_limit": "7.60", 
                                                            "@value": "5.34"
                                                        }
                                                    ]
                                                }, 
                                                "sub_title": "B"
                                            }
                                        ]
                                    }, 
                                    "description": "Influenza virus antibodies were measured using a HAI assay. Geometric mean titer ratio is the geometric mean of the individual post-vaccination / pre-vaccination titer of antibodies to the influenza virus antigens", 
                                    "dispersion": "95% Confidence Interval", 
                                    "param": "Geometric Mean", 
                                    "title": "Geometric Mean Titer Ratios (GMTRs) of Antibodies to Influenza Virus Antigens Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation).", 
                                    "units": "Ratio"
                                }
                            ]
                        }, 
                        "population": "Geometric mean titer ratios against the influenza virus antigens were assessed in the Per-protocol Analysis Set.", 
                        "safety_issue": "No", 
                        "time_frame": "Day 0 (pre-vaccination) and Day 28 after final vaccination", 
                        "title": "Geometric Mean Titer Ratios (GMTRs) of Antibodies to Influenza Virus Antigens Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation).", 
                        "type": "Other Pre-specified"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Participants 6 months to < 36 months of age that received one or two doses of 0.25 mL of Fluzone vaccine", 
                            "title": "Age 6 to < 36 Months Group"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Participants 3 years to < 9 years of age that received one or two doses 0.5 mL of Fluzone vaccine", 
                            "title": "Age 3 to < 9 Years Group"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "30", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "30", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "30", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "30", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "0", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }, 
                "pre_assignment_details": "A total of 60 participants who met all of the inclusion and none of the exclusion criteria were randomized and vaccinated in this study.", 
                "recruitment_details": "The study participants were enrolled from 19 September 2012 to 12 December 2012 at 2 clinic centers in the United States."
            }, 
            "point_of_contact": {
                "email": "RegistryContactUs@sanofipasteur.com", 
                "name_or_title": "Medical Director", 
                "organization": "Sanofi Pasteur Inc."
            }, 
            "reported_events": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Participants 6 months to < 36 months of age that received  one or two doses of 0.25 mL  of Fluzone vaccine", 
                            "title": "6 to < 36 Months Age Group"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Participants 3 years to < 9 years of age that received  one or two doses of 0.5 mL of Fluzone vaccine", 
                            "title": "3 to < 9 Years Age Group"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "9", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "13", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@events": "4", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Diarrhoea"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "0"
                                                }
                                            ], 
                                            "sub_title": "Vomiting"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "2", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Pyrexia"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "8", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "0"
                                                }
                                            ], 
                                            "sub_title": "Injection site Tenderness"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "8", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "13", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Injection site Pain"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "8", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "9", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Injection site Erythema"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "5", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "7", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Injection site Swelling"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "2", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "30"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "28"
                                                }
                                            ], 
                                            "sub_title": "Fever"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "4", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "4", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Malaise"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "5", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Upper respiratory tract infection"
                                    }
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Systematic Assessment", 
                                        "counts": [
                                            {
                                                "@events": "4", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "4", 
                                                "@subjects_at_risk": "15"
                                            }, 
                                            {
                                                "@events": "0", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "0"
                                            }
                                        ], 
                                        "sub_title": "Loss of Appetite"
                                    }
                                }, 
                                "title": "Metabolism and nutrition disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "assessment": "Systematic Assessment", 
                                        "counts": [
                                            {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "3", 
                                                "@subjects_at_risk": "15"
                                            }, 
                                            {
                                                "@events": "2", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Myalgia"
                                    }
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "5", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "0"
                                                }
                                            ], 
                                            "sub_title": "Drowsiness"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "1", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "5", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "30"
                                                }
                                            ], 
                                            "sub_title": "Headache"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "6", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "0"
                                                }
                                            ], 
                                            "sub_title": "Abnormal crying"
                                        }, 
                                        {
                                            "assessment": "Systematic Assessment", 
                                            "counts": [
                                                {
                                                    "@events": "9", 
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "15"
                                                }, 
                                                {
                                                    "@events": "0", 
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "0"
                                                }
                                            ], 
                                            "sub_title": "Irritability"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@events": "3", 
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }, 
                                            {
                                                "@events": "2", 
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "30"
                                            }
                                        ], 
                                        "sub_title": "Cough"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Non-systematic Assessment", 
                    "default_vocab": "MedDRA 15.0 version", 
                    "frequency_threshold": "5.00"
                }, 
                "time_frame": "Adverse event data were collected from Day 0 (post-vaccination) up to Day 28 after final vaccination."
            }
        }, 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Influenza", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "detailed_description": {
            "textblock": "All participants will receive Fluzone vaccine during Visit 1. For subjects receiving 2 doses\n      of influenza vaccine, per ACIP guidance, a second dose of Fluzone vaccine will be\n      administered during Visit 2.\n\n      Total duration of participation in the study is approximately 28 days for participants\n      receiving 1 dose and 56 days for those receiving 2 doses of Fluzone vaccine."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is 6 months to < 9 years of age on the day of inclusion\n\n          -  Parent/guardian is willing and able to attend scheduled visits and to comply with the\n             study procedures during the entire duration of the study\n\n          -  Assent form has been signed and dated by subjects 7 to < 9 years of age, and informed\n             consent form has been signed and dated by parent(s) or another legally acceptable\n             representative\n\n          -  For subjects 6 months to < 24 months of age, born at full term of pregnancy (\u2265 37\n             weeks) and with a birth weight \u2265 2.5 kg (5.5 lbs).\n\n        Exclusion Criteria:\n\n          -  Known systemic hypersensitivity to eggs, chicken proteins, latex, or any of the\n             vaccine components, or a history of a life-threatening reaction to Fluzone vaccine or\n             to a vaccine containing any of the same substances (the complete list of vaccine\n             components is included in the Prescribing Information)\n\n          -  History of serious adverse reaction to any influenza vaccine\n\n          -  Receipt of any vaccine within 30 days before receiving study vaccine, or plans to\n             receive another vaccine before Visit 2 for subjects receiving 1 influenza vaccine or\n             Visit 3 for subjects receiving 2 doses of influenza vaccine\n\n          -  Participation in another interventional clinical trial investigating a vaccine, drug,\n             medical device, or medical procedure in the 30 days preceding the first study\n             vaccination or during the course of the study unless no intervention for the other\n             study occurred within the 30 days prior to the first study vaccination and none are\n             planned before the subject would complete safety surveillance for the present study\n\n          -  Prior vaccination with any formulation of 2012-2013 influenza vaccine\n\n          -  Bleeding disorder or receipt of anticoagulants in the 3 weeks preceding inclusion,\n             which may be a contraindication for intramuscular (IM) vaccination, at the discretion\n             of the Investigator\n\n          -  Thrombocytopenia, which may be a contraindication for IM vaccination, at the\n             discretion of the Investigator\n\n          -  Any condition that in the opinion of the Investigator would pose a health risk to the\n             subject if enrolled or could interfere with the evaluation of the vaccine\n\n          -  Personal history of Guillain-Barr\u00e9 syndrome\n\n          -  Known or suspected congenital or acquired immunodeficiency; or receipt of\n             immunosuppressive therapy such as anti-cancer chemotherapy or radiation therapy\n             within the preceding 6 months; or long-term systemic corticosteroid therapy\n             (prednisone or equivalent for more than 2 consecutive weeks within the past 3 months)\n\n          -  Personal history of clinically significant developmental delay (at the discretion of\n             the Investigator), neurologic disorder, or seizure disorder\n\n          -  Chronic illness that, in the opinion of the Investigator, is at a stage where it\n             might interfere with trial conduct or completion\n\n          -  Known seropositivity for human immunodeficiency virus (HIV), hepatitis B, or\n             hepatitis C\n\n          -  Moderate or severe acute illness/infection (according to investigator judgment) on\n             the day of vaccination or febrile illness (temperature \u2265 100.4\u00b0F). A prospective\n             subject should not be included in the study until the condition has resolved or the\n             febrile event has subsided\n\n          -  Receipt of immune globulins, blood, or blood-derived products in the past 3 months\n\n          -  Identified as a natural or adopted child of the Investigator or an employee with\n             direct involvement in the proposed study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "8 Years", 
            "minimum_age": "6 Months"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 19, 2012", 
        "firstreceived_results_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01691326", 
            "org_study_id": "GRC49", 
            "secondary_id": "U1111-1124-8218"
        }, 
        "intervention": [
            {
                "arm_group_label": "6 months to < 36 months of age group", 
                "description": "0.25 mL dose, Intramuscular", 
                "intervention_name": "Fluzone\u00ae: Influenza Virus Vaccine, No Preservative: Pediatric Dose", 
                "intervention_type": "Biological", 
                "other_name": "Fluzone\u00ae (Influenza Virus Vaccine) 2012-2013 Formulation"
            }, 
            {
                "arm_group_label": "3 years to < 9 years of age group", 
                "description": "0.5 mL dose, Intramuscular", 
                "intervention_name": "Fluzone\u00ae; Influenza Virus Vaccine, No Preservative", 
                "intervention_type": "Biological", 
                "other_name": "Fluzone\u00ae (Influenza Virus Vaccine) 2012 2013 Formulation"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Influenza", 
            "Fluzone\u00ae (Influenza Virus Vaccine) 2012-2013 Formulation", 
            "Influenza virus vaccine", 
            "Trivalent Inactivated Influenza Vaccine"
        ], 
        "lastchanged_date": "March 12, 2014", 
        "link": [
            {
                "url": "http://www.sanofipasteur.com"
            }, 
            {
                "url": "http://www.sanofi.com"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Bardstown", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40004"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84124"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Safety and Immunogenicity Among Healthy Children Receiving Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
        "other_outcome": [
            {
                "description": "The influenza virus antibodies were measured using a hemagglutination inhibition (HAI) assay.", 
                "measure": "Geometric Mean Titers of Antibodies to Influenza Antigens Before and Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation).", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (pre-vaccination) and Day 28 after final vaccination"
            }, 
            {
                "description": "Influenza virus antibodies were measured using a HAI assay. Seroprotection was defined as a titer \u226540 (1/dilution).", 
                "measure": "Number of Participants With Seroprotection Before and Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (pre-vaccination) and Day 28 after final vaccination"
            }, 
            {
                "description": "Influenza virus antibodies were measured using a HAI assay. Seroconversion was defined as a pre-vaccination titer <10 (1/dilution) and a post-vaccination titer \u226540 (1/dilution), or a pre-vaccination titer \u226510 (1/dilution) and \u22654-fold increase in titer 28 days after final vaccination.", 
                "measure": "Number of Participants With Seroconversion Against Influenza Virus Antigens Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
                "safety_issue": "No", 
                "time_frame": "Day 28 after final vaccination"
            }, 
            {
                "description": "Influenza virus antibodies were measured using a HAI assay. Geometric mean titer ratio is the geometric mean of the individual post-vaccination / pre-vaccination titer of antibodies to the influenza virus antigens", 
                "measure": "Geometric Mean Titer Ratios (GMTRs) of Antibodies to Influenza Virus Antigens Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation).", 
                "safety_issue": "No", 
                "time_frame": "Day 0 (pre-vaccination) and Day 28 after final vaccination"
            }
        ], 
        "overall_official": {
            "affiliation": "Sanofi Pasteur Inc.", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Solicited injection site reactions (Age 6 to < 24 Months): Tenderness, Erythema and Swelling. Solicited systemic reactions: Fever (Temperature), Vomiting, Abnormal crying, Drowsiness, Loss of appetite, and Irritability.\nGrade 3: Tenderness, Cries when injected limb is moved; Erythema and Swelling, \u2265 50 mm; Fever, >103.1\u00b0F; Vomiting, \u22656 episodes/24 hours; Abnormal crying, >3 hours; Drowsiness, Sleeping most of the time; Loss of appetite, Refuses \u22653 feeds/meals or most feeds/meals; Irritability, Inconsolable.\nSolicited injection site reactions (Age 24 Months to < 9 Years): Pain, Erythema, and Swelling. Systemic reactions: Fever (Temperature), Headache, Malaise, and Myalgia.\nGrade 3: Pain, Incapacitating, unable to perform usual activities; Redness and Swelling, \u2265 50 mm; Fever: \u2265102.1\u00b0F; Headache, Malaise, and Myalgia, Significant, prevents daily activity.", 
            "measure": "Number of Participants Reporting Solicited Injection Site or Systemic Reactions Following Vaccination With Fluzone\u00ae Influenza Virus Vaccine (2012-2013 Formulation)", 
            "safety_issue": "No", 
            "time_frame": "Day 0 up to Day 7 post-vaccination"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01691326"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Sanofi", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sanofi Pasteur, a Sanofi Company", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}